1
|
Li L, Zhong W, Liu H, Espinosa-Artiles P, Xu YM, Wang C, Robles JMV, Paz TA, Inácio MC, Chen F, Xu Y, Gunatilaka AAL, Molnár I. Biosynthesis of Cytosporones in Leotiomycetous Filamentous Fungi. J Am Chem Soc 2024; 146:6189-6198. [PMID: 38386630 PMCID: PMC11106036 DOI: 10.1021/jacs.3c14066] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/24/2024]
Abstract
Polyketides with the isochroman-3-one pharmacophore are rare among fungal natural products as their biosynthesis requires an unorthodox S-type aromatic ring cyclization. Genome mining uncovered a conserved gene cluster in select leotiomycetous fungi that encodes the biosynthesis of cytosporones, including isochroman-3-one congeners. Combinatorial biosynthesis in total biosynthetic and biocatalytic formats in Saccharomyces cerevisiae and in vitro reconstitution of key reactions with purified enzymes revealed how cytosporone structural and bioactivity diversity is generated. The S-type acyl dihydroxyphenylacetic acid (ADA) core of cytosporones is assembled by a collaborating polyketide synthase pair. Thioesterase domain-catalyzed transesterification releases ADA esters, some of which are known Nur77 modulators. Alternatively, hydrolytic release allows C6 hydroxylation by a flavin-dependent monooxygenase, yielding a trihydroxybenzene moiety. Reduction of the C9 carbonyl by a short chain dehydrogenase/reductase initiates isochroman-3-one formation, affording cytosporones with cytotoxic and antimicrobial activity. Enoyl di- or trihydroxyphenylacetic acids are generated as shunt products, while isocroman-3,4-diones are formed by autoxidation. The cytosporone pathway offers novel polyketide biosynthetic enzymes for combinatorial synthetic biology to advance the production of "unnatural" natural products for drug discovery.
Collapse
Affiliation(s)
- Li Li
- Southwest Center for Natural Products Research, University of Arizona, Tucson 85719, Arizona, United States
- College of Life Science, Yangtze University, Jingzhou 434025, P. R. China
| | - Weimao Zhong
- Southwest Center for Natural Products Research, University of Arizona, Tucson 85719, Arizona, United States
| | - Hang Liu
- Southwest Center for Natural Products Research, University of Arizona, Tucson 85719, Arizona, United States
- Biotechnology Research Institute, Chinese Academy of Agricultural Sciences, Beijing 100081, P. R. China
| | - Patricia Espinosa-Artiles
- Southwest Center for Natural Products Research, University of Arizona, Tucson 85719, Arizona, United States
| | - Ya-ming Xu
- Southwest Center for Natural Products Research, University of Arizona, Tucson 85719, Arizona, United States
| | - Chen Wang
- Southwest Center for Natural Products Research, University of Arizona, Tucson 85719, Arizona, United States
- Biotechnology Research Institute, Chinese Academy of Agricultural Sciences, Beijing 100081, P. R. China
| | - Jose Manuel Verdugo Robles
- Southwest Center for Natural Products Research, University of Arizona, Tucson 85719, Arizona, United States
| | - Tiago Antunes Paz
- School of Pharmaceutical Sciences of Ribeirão Preto, University of São Paulo, Ribeirão Preto 14040-903, Brazil
| | - Marielle Cascaes Inácio
- Southwest Center for Natural Products Research, University of Arizona, Tucson 85719, Arizona, United States
| | - Fusheng Chen
- School of Life Sciences, Guizhou Normal University, Guiyang 550025, P. R. China
- College of Food Science and Technology, Huazhong Agricultural University, Wuhan 430070, P. R. China
| | - Yuquan Xu
- Biotechnology Research Institute, Chinese Academy of Agricultural Sciences, Beijing 100081, P. R. China
| | - A. A. Leslie Gunatilaka
- Southwest Center for Natural Products Research, University of Arizona, Tucson 85719, Arizona, United States
| | - István Molnár
- Southwest Center for Natural Products Research, University of Arizona, Tucson 85719, Arizona, United States
- VTT Technical Research Center of Finland Ltd., Espoo 02150, Finland
| |
Collapse
|
2
|
Correa WA, das Neves SC, Oliveira RJ, Kassuya CA, Navarro SD, Faustino Martins AC, Saroja B, Mitsuyasu B, Ostaciana Maia Freitas da Silveira I, Vitor N, Coelho HRS, Vilela MLB, do Nascimento VA, de Lima DP, Beatriz A, da Silva Gomes R. Chemotherapeutic Mechanism of Action of the Synthetic Resorcinolic Methyl 3,5-dimethoxy-2-octanoylbenzoate. Chem Res Toxicol 2024; 37:259-273. [PMID: 38183658 DOI: 10.1021/acs.chemrestox.3c00269] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/08/2024]
Abstract
Resorcinolic lipids are described as potential examples of selective chemotherapeutic adjuvants that can enhance the effects of cyclophosphamide (CYC) while promoting cell death without causing DNA damage. Therefore, the current study attempted to describe how the resorcinolic lipid methyl 3,5-dimethoxy-2-octanoylbenzoate (AMS35BB) interacted with DNA (DNA docking) and how this compound affected genetic toxicology models and other biological characteristics when combined with CYC. We observed that AMS35BB, used alone (7.5 and 10 mg/kg), increases the frequency of genomic damage (comet assay) but not chromosomal damage (micronuclei assay), lowers phagocytosis, and promotes cell death in Swiss male mice. When used in association with CYC, AMS35BB can reduce the risk of genomic damage by up to 33.8% as well as chromosomal damage, splenic phagocytosis, cell death, and lymphocyte frequency. Molecular docking showed that AMS35BB had a higher affinity than the active metabolite of CYC for binding to the DNA double helix major groove. As a result, AMS35BB has the potential to be both an adjuvant when used in association with CYC and a therapeutic candidate for the development of a selective chemotherapeutic drug.
Collapse
Affiliation(s)
- Willian Ayala Correa
- Institute of Chemistry, Federal University of Mato Grosso do Sul, Campo Grande, Mato Grosso do Sul 79070-900, Brazil
| | - Silvia Cordeiro das Neves
- Stem Cell, Cell Therapy and Toxicological Genetics Research Centre (CeTroGen), Medical School, Federal University of Mato Grosso do Sul, Campo Grande, Mato Grosso do Sul 79080-190, Brazil
- Graduate Program in Health and Development in the Midwest Region, Medical School, Federal University of Mato Grosso do Sul, Campo Grande, Mato Grosso do Sul 79070-900, Brazil
| | - Rodrigo Juliano Oliveira
- Stem Cell, Cell Therapy and Toxicological Genetics Research Centre (CeTroGen), Medical School, Federal University of Mato Grosso do Sul, Campo Grande, Mato Grosso do Sul 79080-190, Brazil
- Graduate Program in Health and Development in the Midwest Region, Medical School, Federal University of Mato Grosso do Sul, Campo Grande, Mato Grosso do Sul 79070-900, Brazil
| | - Cândida A Kassuya
- School of Health Sciences, Federal University of Grande Dourados, Dourados, Mato Grosso do Sul 79804-970, Brazil
| | - Stephanie D Navarro
- Institute of Chemistry, Federal University of Mato Grosso do Sul, Campo Grande, Mato Grosso do Sul 79070-900, Brazil
- Stem Cell, Cell Therapy and Toxicological Genetics Research Centre (CeTroGen), Medical School, Federal University of Mato Grosso do Sul, Campo Grande, Mato Grosso do Sul 79080-190, Brazil
| | | | - Baby Saroja
- Department of Pharmaceutical Sciences, North Dakota State University, Fargo, North Dakota 58102, United States
| | - Barbara Mitsuyasu
- Department of Pharmaceutical Sciences, North Dakota State University, Fargo, North Dakota 58102, United States
- Department of Chemical and Biological Sciences, Institute of Biosciences, São Paulo State University (UNESP), Botucatu, São Paulo 18618-689, Brazil
| | | | - Neimar Vitor
- Institute of Chemistry, Federal University of Mato Grosso do Sul, Campo Grande, Mato Grosso do Sul 79070-900, Brazil
| | - Henrique Rodrigues Scherer Coelho
- Stem Cell, Cell Therapy and Toxicological Genetics Research Centre (CeTroGen), Medical School, Federal University of Mato Grosso do Sul, Campo Grande, Mato Grosso do Sul 79080-190, Brazil
| | - Marcelo L B Vilela
- Institute of Chemistry, Federal University of Mato Grosso do Sul, Campo Grande, Mato Grosso do Sul 79070-900, Brazil
| | - Valter A do Nascimento
- Graduate Program in Health and Development in the Midwest Region, Medical School, Federal University of Mato Grosso do Sul, Campo Grande, Mato Grosso do Sul 79070-900, Brazil
| | - Dênis P de Lima
- Institute of Chemistry, Federal University of Mato Grosso do Sul, Campo Grande, Mato Grosso do Sul 79070-900, Brazil
| | - Adilson Beatriz
- Institute of Chemistry, Federal University of Mato Grosso do Sul, Campo Grande, Mato Grosso do Sul 79070-900, Brazil
| | - Roberto da Silva Gomes
- Department of Pharmaceutical Sciences, North Dakota State University, Fargo, North Dakota 58102, United States
| |
Collapse
|
3
|
Rezende GCD, Noronha RCR, Ortiz HC, do Nascimento LAS, das Neves SC, Ventura Said YL, Cardoso AL, de Mescouto VA, Vilela MLB, do Nascimento VA, Coelho HRS, Leite Kassuya CA, Pedroso TF, Salvador MJ, Oliveira RJ. Absence of maternal-fetal adverse effects of Alternanthera littoralis P. Beauv. following treatment during pregnancy in mice. JOURNAL OF TOXICOLOGY AND ENVIRONMENTAL HEALTH. PART A 2023; 86:543-556. [PMID: 37340982 DOI: 10.1080/15287394.2023.2223624] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 06/22/2023]
Abstract
Alternanthera littoralis P. Beauv is a plant native to Brazil that exhibits various beneficial activities including antioxidant, antibacterial, antifungal, antiprotozoal, anti-hyperalgesic, and anti-inflammatory properties. The aim of this study was to assess the impact of the ethanol extract of Alternanthera littoralis (EEAl) on reproductive outcomes, embryofetal development, and DNA integrity of pregnant female mice. Pregnant Swiss female mice were randomly assigned to three experimental groups (n = 10): controls were administered either 1% Tween 80 (vehicle), EEAl 100 mg/kg or EEAl 1000 mg/kg. Treatment was administered through gavage during the gestational period until day 18. On gestational days 16, 17, and 18, a peripheral blood sample from the tail vein was obtained for DNA integrity analysis (micronucleus test). After the last collection, animals were euthanized by cervical dislocation. Maternal organs and fetuses were collected, weighed, and subsequently analyzed. Reproductive outcome parameters were assessed by measurement of number of implants, live fetuses, and resorptions. Embryonic development was determined by adequacy of weight for gestational age as well as determination of external, visceral, and skeletal malformations. Data demonstrated that EEAl did not produce maternal toxicity at either dose associated with no marked alterations in any of the reproductive outcome parameters including implantation sites, live/dead fetuses ratio, fetal viability, post-implantation losses, resorptions, and resorption rate. However, EEAl 1000 group reduced embryofetal development by lowering placental weight. In addition, there was an increase in the frequency of external and skeletal malformations in the EEAl 1000 group, which could not be attributed to extract exposure as these values were within control levels. Based upon our findings, evidence indicates that the EEAl at the concentrations employed in our study may be considered safe for use during pregnancy and extracts of this plant show potential for development of phytomedicines to be used in pregnancy.
Collapse
Affiliation(s)
- Giovana Corbucci Danti Rezende
- Centro de Estudos em Células-Tronco, Terapia Celular e Genética Toxicológica (CeTroGen), Faculdade de Medicina (FAMED), Universidade Federal de Mato Grosso do Sul (UFMS), Campo Grande, Mato Grosso do Sul, Brasil
- Programa de Pós-Graduação em Saúde e Desenvolvimento na Região Centro-Oeste, Faculdade de Medicina (FAMED), Universidade Federal de Mato Grosso do Sul (UFMS), Campo Grande, Mato Grosso do Sul, Brasil
| | - Renata Coelho Rodrigues Noronha
- Laboratório de Citogenética, Centro de Estudos Avançados da Biodiversidade, Instituto de Ciências Biológicas (ICB), Universidade Federal Do Pará (UFPA), Belém, Brasil
| | - Hudman Cunha Ortiz
- Centro de Estudos em Células-Tronco, Terapia Celular e Genética Toxicológica (CeTroGen), Faculdade de Medicina (FAMED), Universidade Federal de Mato Grosso do Sul (UFMS), Campo Grande, Mato Grosso do Sul, Brasil
- Programa de Pós-Graduação em Saúde e Desenvolvimento na Região Centro-Oeste, Faculdade de Medicina (FAMED), Universidade Federal de Mato Grosso do Sul (UFMS), Campo Grande, Mato Grosso do Sul, Brasil
| | | | - Silvia Cordeiro das Neves
- Centro de Estudos em Células-Tronco, Terapia Celular e Genética Toxicológica (CeTroGen), Faculdade de Medicina (FAMED), Universidade Federal de Mato Grosso do Sul (UFMS), Campo Grande, Mato Grosso do Sul, Brasil
- Programa de Pós-Graduação em Saúde e Desenvolvimento na Região Centro-Oeste, Faculdade de Medicina (FAMED), Universidade Federal de Mato Grosso do Sul (UFMS), Campo Grande, Mato Grosso do Sul, Brasil
| | - Yasmin Lany Ventura Said
- Centro de Estudos em Células-Tronco, Terapia Celular e Genética Toxicológica (CeTroGen), Faculdade de Medicina (FAMED), Universidade Federal de Mato Grosso do Sul (UFMS), Campo Grande, Mato Grosso do Sul, Brasil
- Programa de Pós-Graduação em Saúde e Desenvolvimento na Região Centro-Oeste, Faculdade de Medicina (FAMED), Universidade Federal de Mato Grosso do Sul (UFMS), Campo Grande, Mato Grosso do Sul, Brasil
| | - Adauto Lima Cardoso
- Laboratório de Citogenética, Centro de Estudos Avançados da Biodiversidade, Instituto de Ciências Biológicas (ICB), Universidade Federal Do Pará (UFPA), Belém, Brasil
- Programa de Pós-Graduação em Biotecnologia, Universidade Federal do Pará (UFPA), Belém, Brasil
- Laboratório Genômica Integrativa, Departamento de Biologia Estrutural e Funcional, Instituto de Biociências de Botucatu (IBB), Universidade Estadual Paulista (UNESP), Botucatu, São Paulo, Brasil
| | | | - Marcelo Luiz Brandão Vilela
- Faculdade de Medicina (FAMED), Universidade Federal de Mato Grosso do Sul (UFMS), Campo Grande, Mato Grosso do Sul, Brasil
| | - Valter Aragão do Nascimento
- Programa de Pós-Graduação em Saúde e Desenvolvimento na Região Centro-Oeste, Faculdade de Medicina (FAMED), Universidade Federal de Mato Grosso do Sul (UFMS), Campo Grande, Mato Grosso do Sul, Brasil
| | - Henrique Rodrigues Scherer Coelho
- Centro de Estudos em Células-Tronco, Terapia Celular e Genética Toxicológica (CeTroGen), Faculdade de Medicina (FAMED), Universidade Federal de Mato Grosso do Sul (UFMS), Campo Grande, Mato Grosso do Sul, Brasil
| | | | - Taise Fonseca Pedroso
- Departamento de Biologia Vegetal, Instituto de Biologia, Universidade Estadual de Campinas (UNICAMP), São Paulo, Brasil
| | - Marcos José Salvador
- Departamento de Biologia Vegetal, Instituto de Biologia, Universidade Estadual de Campinas (UNICAMP), São Paulo, Brasil
| | - Rodrigo Juliano Oliveira
- Centro de Estudos em Células-Tronco, Terapia Celular e Genética Toxicológica (CeTroGen), Faculdade de Medicina (FAMED), Universidade Federal de Mato Grosso do Sul (UFMS), Campo Grande, Mato Grosso do Sul, Brasil
- Programa de Pós-Graduação em Saúde e Desenvolvimento na Região Centro-Oeste, Faculdade de Medicina (FAMED), Universidade Federal de Mato Grosso do Sul (UFMS), Campo Grande, Mato Grosso do Sul, Brasil
| |
Collapse
|
4
|
das Neves SC, de Araújo FH, Correa WA, Martins ACF, Coelho HRS, Vilela MLB, do Nascimento VA, Kassuya CAL, de Lima DP, Beatriz A, Oliveira RJ, Gomes RDS. 3-Heptylidene-4,6-Dimethoxy-3 H-Isobenzofuran-1-One Is Genotoxic, Increases the Frequency of Cell Death, and Potentiates the Effects of Cyclophosphamide and Cisplatin. Molecules 2023; 28:1044. [PMID: 36770711 PMCID: PMC9922015 DOI: 10.3390/molecules28031044] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/01/2022] [Revised: 01/17/2023] [Accepted: 01/18/2023] [Indexed: 01/22/2023] Open
Abstract
3-heptylidene-4,6-dimethoxy-3H-isobenzofuran-1-one (Phthalide 1) is the precursor of three resorcinol lipids that have been described as potential chemotherapeutic agents and capable of potentiating the effects of cyclophosphamide. In this study, we evaluated the genotoxic potential, cell-killing potential, and interactions with cyclophosphamide and cisplatin of phthalide 1. Twelve groups were created from 120 mice: Negative Control, cyclophosphamide (100 mg/kg), cisplatin (6 mg/kg), Phthalide 1 (5, 10 and 20 mg/kg), and associations of 1 with cyclophosphamide and 1 with cisplatin. The results demonstrate that 1 increases (p < 0.05) the frequency of chromosomal damage, liver and kidney cell death, and splenic phagocytosis. The association of 1 with cyclophosphamide and cisplatin demonstrated a chemopreventive effect and, therefore, a reduction (p < 0.05) in the frequency of chromosomal damage. However, cell death and splenic phagocytosis did not suffer significant variations. As a result of the above, 1 has potential chemotherapeutic application and may be a candidate for developing a new generation of chemotherapeutics. In addition, it has characteristics to be used as a chemotherapy adjuvant in association with cyclophosphamide and cisplatin since it increases the frequency of cell death induced by chemotherapy. We also reported that the chemopreventive effect of 1, in association with cyclophosphamide and cisplatin, can prevent adverse effects (induction of DNA damage in non-tumor cells) without interfering with the mode of action of chemotherapy drugs and, therefore, without reducing the induction of cell death.
Collapse
Affiliation(s)
- Silvia Cordeiro das Neves
- Stem Cell, Cell Therapy and Toxicological Genetics Research Centre (CeTroGen), Medical School, Federal University of Mato Grosso do Sul, Campo Grande 79080-190, MS, Brazil
- Graduate Programme in Health and Development in the Midwest Region, Medical School, Federal University of Mato Grosso do Sul, Campo Grande 79070-900, MS, Brazil
| | - Flavio Henrique de Araújo
- Stem Cell, Cell Therapy and Toxicological Genetics Research Centre (CeTroGen), Medical School, Federal University of Mato Grosso do Sul, Campo Grande 79080-190, MS, Brazil
| | - Willian Ayala Correa
- Institute of Chemistry, Federal University of Mato Grosso do Sul, Campo Grande 79070-900, MS, Brazil
| | | | - Henrique Rodrigues Scherer Coelho
- Stem Cell, Cell Therapy and Toxicological Genetics Research Centre (CeTroGen), Medical School, Federal University of Mato Grosso do Sul, Campo Grande 79080-190, MS, Brazil
| | | | - Valter Aragão do Nascimento
- Graduate Programme in Health and Development in the Midwest Region, Medical School, Federal University of Mato Grosso do Sul, Campo Grande 79070-900, MS, Brazil
| | | | - Dênis Pires de Lima
- Institute of Chemistry, Federal University of Mato Grosso do Sul, Campo Grande 79070-900, MS, Brazil
| | - Adilson Beatriz
- Institute of Chemistry, Federal University of Mato Grosso do Sul, Campo Grande 79070-900, MS, Brazil
| | - Rodrigo Juliano Oliveira
- Stem Cell, Cell Therapy and Toxicological Genetics Research Centre (CeTroGen), Medical School, Federal University of Mato Grosso do Sul, Campo Grande 79080-190, MS, Brazil
- Graduate Programme in Health and Development in the Midwest Region, Medical School, Federal University of Mato Grosso do Sul, Campo Grande 79070-900, MS, Brazil
| | - Roberto da Silva Gomes
- Department of Pharmaceutical Sciences, North Dakota State University, Fargo, ND 58102, USA
| |
Collapse
|
5
|
Oliveira RJ, da Silveira IOMF, das Neves SC, Mitsuyasu B, Martins AC, Berno C, Mohammad J, Raj H, de Araujo FHS, Hortelan CR, Machado L, da Silva Júnior EN, Vilela MLB, Nascimento VA, Beatriz A, da Silva Gomes R. ZIM, a Norbornene Derived from 4-Aminoantipyrine, Induces DNA Damage and Cell Death but in Association Reduces the Effect of Commercial Chemotherapeutics. Chem Res Toxicol 2023; 36:66-82. [PMID: 36548215 DOI: 10.1021/acs.chemrestox.2c00275] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/24/2022]
Abstract
Cancer incidence is increasing, and the drugs are not very selective. These drugs cause adverse effects, and the cells become resistant. Therefore, new drugs are needed. Here, we evaluated the effects of ZIM, a candidate for chemotherapy, and 4-AA alone and in association with commercial chemotherapeutic agents. Subsequently, the results of ZIM and 4-AA were compared. Male Swiss mice were treated with doses of 12, 24, or 48 mg/kg ZIM or 4-AA alone or in association with cisplatin (6 mg/kg), doxorubicin (16 mg/kg), and cyclophosphamide (100 mg/kg). Biometric parameters, DNA damage (comet and micronuclei), cell death, and splenic phagocytosis were evaluated. DNA docking was also performed to confirm the possible interactions of ZIM and 4-AA with DNA. 4-AA has been shown to have low genotoxic potential, increase the frequency of cell death, and activate phagocytosis. ZIM causes genomic and chromosomal damage in addition to causing cell death and activating phagocytosis. In association with chemotherapeutical agents, both 4-AA and ZIM have a chemopreventive effect and, therefore, reduce the frequency of DNA damage, cell death, and splenic phagocytosis. The association of 4-AA and ZIM with commercial chemotherapeutic agents increased the frequency of lymphocytes compared to chemotherapeutic agents alone. Molecular docking demonstrated that ZIM has more affinity for DNA than 4-AA and its precursors (1 and 2). This was confirmed by the lower interaction energy of the complex (-119.83 kcal/mol). ZIM can break the DNA molecule and, therefore, its chemotherapeutic effect can be related to DNA damage. It is considered that ZIM has chemotherapeutic potential. However, it should not be used in combination with cisplatin, doxorubicin, and cyclophosphamide as it reduces the effects of these drugs.
Collapse
Affiliation(s)
- Rodrigo Juliano Oliveira
- Stem Cell, Cell Therapy and Toxicological Genetics Research Centre (CeTroGen), Medical School, Federal University of Mato Grosso do Sul, Campo Grande, Mato Grosso do Sul79080-190, Brazil.,Graduate Program in Health and Development in the Midwest Region, Medical School, Federal University of Mato Grosso do Sul, Campo Grande, Mato Grosso do Sul79070-900, Brazil
| | - Ingridhy Ostaciana Maia Freitas da Silveira
- Institute of Chemistry, Federal University of Mato Grosso do Sul, Campo Grande, Mato Grosso do Sul79070-900, Brazil.,Department of Pharmaceutical Sciences, North Dakota State University, Fargo, North Dakota58102, United States
| | - Silvia C das Neves
- Stem Cell, Cell Therapy and Toxicological Genetics Research Centre (CeTroGen), Medical School, Federal University of Mato Grosso do Sul, Campo Grande, Mato Grosso do Sul79080-190, Brazil.,Graduate Program in Health and Development in the Midwest Region, Medical School, Federal University of Mato Grosso do Sul, Campo Grande, Mato Grosso do Sul79070-900, Brazil
| | - Barbara Mitsuyasu
- Department of Pharmaceutical Sciences, North Dakota State University, Fargo, North Dakota58102, United States.,Department of Chemical and Biological Sciences, Institute of Biosciences, São Paulo State University (UNESP), Botucatu, SP18618-689, Brazil
| | - Allana C Martins
- Department of Pharmaceutical Sciences, North Dakota State University, Fargo, North Dakota58102, United States
| | - Claudia Berno
- Stem Cell, Cell Therapy and Toxicological Genetics Research Centre (CeTroGen), Medical School, Federal University of Mato Grosso do Sul, Campo Grande, Mato Grosso do Sul79080-190, Brazil
| | - Jiyan Mohammad
- Department of Pharmaceutical Sciences, North Dakota State University, Fargo, North Dakota58102, United States
| | - Halie Raj
- Department of Pharmaceutical Sciences, North Dakota State University, Fargo, North Dakota58102, United States
| | - Flavio H S de Araujo
- Stem Cell, Cell Therapy and Toxicological Genetics Research Centre (CeTroGen), Medical School, Federal University of Mato Grosso do Sul, Campo Grande, Mato Grosso do Sul79080-190, Brazil
| | | | - Luana Machado
- Institute of Exact Sciences, Department of Chemistry, Federal University of Minas Gerais, Belo Horizonte, MGCEP 31270-901, Brazil.,Department of Chemistry, Fluminense Federal University, Niteroi, RJ24020-141, Brazil
| | - Eufrânio N da Silva Júnior
- Institute of Exact Sciences, Department of Chemistry, Federal University of Minas Gerais, Belo Horizonte, MGCEP 31270-901, Brazil
| | - Marcelo L B Vilela
- Medical School, Federal University of Mato Grosso do Sul, Campo Grande, Mato Grosso do Sul79070-900, Brazil
| | - Valter Aragão Nascimento
- Graduate Program in Health and Development in the Midwest Region, Medical School, Federal University of Mato Grosso do Sul, Campo Grande, Mato Grosso do Sul79070-900, Brazil
| | - Adilson Beatriz
- Institute of Chemistry, Federal University of Mato Grosso do Sul, Campo Grande, Mato Grosso do Sul79070-900, Brazil
| | - Roberto da Silva Gomes
- Department of Pharmaceutical Sciences, North Dakota State University, Fargo, North Dakota58102, United States
| |
Collapse
|
6
|
Sadıkoğulları BC, Şenel P, Çini N, Faysal AA, Odabaşoğlu M, Özdemir AD, Gölcü A. An Overview of Natural and Synthetic Phthalides Involved in Cancer Studies: Past, Present, and Future. ChemistrySelect 2022. [DOI: 10.1002/slct.202202004] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/11/2022]
Affiliation(s)
- Bleda Can Sadıkoğulları
- Istanbul Technical University Faculty of Sciences and Letters Department of Chemistry Istanbul 34469 Turkey
| | - Pelin Şenel
- Istanbul Technical University Faculty of Sciences and Letters Department of Chemistry Istanbul 34469 Turkey
| | - Nejla Çini
- Istanbul Technical University Faculty of Sciences and Letters Department of Chemistry Istanbul 34469 Turkey
| | - Abdullah Al Faysal
- Istanbul Technical University Faculty of Sciences and Letters Department of Chemistry Istanbul 34469 Turkey
| | - Mustafa Odabaşoğlu
- Karadeniz Technical University Faculty of Sciences and Letters Department of Chemistry Trabzon 61080 Turkey
| | - Ayşe Daut Özdemir
- Istanbul Technical University Faculty of Sciences and Letters Department of Chemistry Istanbul 34469 Turkey
| | - Ayşegül Gölcü
- Istanbul Technical University Faculty of Sciences and Letters Department of Chemistry Istanbul 34469 Turkey
| |
Collapse
|
7
|
O. M. F. da Silveira I, S. B. Moslaves I, A. I. Muller J, R. W. Hortelan C, Teibel Okuyama T, Fernandes J, Badenoch B, Janaína de Campos L, Almeida LD, Mohammad J, C. F. Martins A, Beatriz A, da Silva Júnior EN, Cristina Toffoli-Kadri M, da Silva Gomes R. Design, Synthesis and in vivo Evaluation of 1,4-dioxo-2-butenyl Aryl Amine Derivatives as a Promising Anti-inflammatory Drug Prototype. Bioorg Chem 2022; 124:105754. [DOI: 10.1016/j.bioorg.2022.105754] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/08/2021] [Revised: 03/11/2022] [Accepted: 03/18/2022] [Indexed: 11/16/2022]
|
8
|
Vasconcelos NG, Vaz MSM, Radai JAS, Kassuya CAL, Formagio ASN, Graciani FS, Leal ML, Oliveira RJ, da Silva KE, Croda J, Simionatto S. Antimicrobial activity of plant extracts against carbapenem-producing Klebsiella pneumoniae and in vivo toxicological assessment. JOURNAL OF TOXICOLOGY AND ENVIRONMENTAL HEALTH. PART A 2020; 83:719-729. [PMID: 32981476 DOI: 10.1080/15287394.2020.1824135] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 06/11/2023]
Abstract
The global spread of multidrug-resistant strains has prompted the scientific community to explore novel sources of chemicals with antimicrobial activity. The aim of the study was to examine the antimicrobial activity in vitro of 28 extracts against carbapenem-producing Klebsiella pneumoniae, individually and in combination with antibiotics and in vivo toxicological assessment of the most active product. The multi-resistant K. pneumoniae strain was submitted for phenotypic and molecular characterization. The antibacterial activity of 28 plant extracts was evaluated alone and in combination with antibiotics against this strain through the agar disk diffusion. Of these, 16 extracts showed synergism against carbapenem-producing K. pneumoniae, being that B. crassifolia extract exhibited synergism with three antibiotics. Based on this assessment, B. crassifolia-extract-induced toxicity on Swiss male mice was evaluated by administering this extract and subsequently determining apoptosis and splenic phagocytosis using the comet and micronucleus assays. The results of this study showed that B. crassifolia extract had synergistic activity promising and groups treated with B. crassifolia exhibited no genotoxic or mutagenic activity, indicating that B. crassifolia extract exerted beneficial effects and appeared safe to use at the studied concentrations.
Collapse
Affiliation(s)
- Nathalie Gaebler Vasconcelos
- Laboratório De Pesquisa Em Ciências Da Saúde, Universidade Federal Da Grande Dourados - UFGD , Dourados, Mato Grosso Do Sul, Brazil
| | - Márcia Soares Mattos Vaz
- Laboratório De Pesquisa Em Ciências Da Saúde, Universidade Federal Da Grande Dourados - UFGD , Dourados, Mato Grosso Do Sul, Brazil
| | - Joyce Alencar Santos Radai
- Laboratório De Pesquisa Em Ciências Da Saúde, Universidade Federal Da Grande Dourados - UFGD , Dourados, Mato Grosso Do Sul, Brazil
| | - Candida Aparecida Leite Kassuya
- Laboratório De Pesquisa Em Ciências Da Saúde, Universidade Federal Da Grande Dourados - UFGD , Dourados, Mato Grosso Do Sul, Brazil
| | - Anelise Samara Nazari Formagio
- Laboratório De Pesquisa Em Ciências Da Saúde, Universidade Federal Da Grande Dourados - UFGD , Dourados, Mato Grosso Do Sul, Brazil
| | - Fernanda Silva Graciani
- Laboratório De Pesquisa Em Ciências Da Saúde, Universidade Federal Da Grande Dourados - UFGD , Dourados, Mato Grosso Do Sul, Brazil
| | - Maria Lorenza Leal
- Laboratório De Pesquisa Em Ciências Da Saúde, Universidade Federal Da Grande Dourados - UFGD , Dourados, Mato Grosso Do Sul, Brazil
| | - Rodrigo Juliano Oliveira
- Faculdade de Medicina, Universidade Federal Do Mato Grosso Do Sul (UFMS) , Campo Grande, MS, Brazil
| | - Kesia Esther da Silva
- Laboratório De Pesquisa Em Ciências Da Saúde, Universidade Federal Da Grande Dourados - UFGD , Dourados, Mato Grosso Do Sul, Brazil
| | - Julio Croda
- Laboratório De Pesquisa Em Ciências Da Saúde, Universidade Federal Da Grande Dourados - UFGD , Dourados, Mato Grosso Do Sul, Brazil
- Faculdade de Medicina, Universidade Federal Do Mato Grosso Do Sul (UFMS) , Campo Grande, MS, Brazil
- Fundação Osvaldo Cruz (FIOCRUZ) , Campo Grande, MS, Brazil
| | - Simone Simionatto
- Laboratório De Pesquisa Em Ciências Da Saúde, Universidade Federal Da Grande Dourados - UFGD , Dourados, Mato Grosso Do Sul, Brazil
| |
Collapse
|
9
|
Yılmaz ZT, Odabaşoğlu HY, Şenel P, Adımcılar V, Erdoğan T, Özdemir AD, Gölcü A, Odabaşoğlu M, Büyükgüngör O. Investigations on crystal structure of a novel 3-((4,6-dimethylpyrimidin-2-yl)amino)isobenzofuran-1(3H)-one, and related theoretical studies. ARAB J CHEM 2020. [DOI: 10.1016/j.arabjc.2020.03.013] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/27/2022] Open
|
10
|
de Oliveira AM, de Freitas AFS, Paiva PMG, Napoleão TH. Genotoxicity assessment of saline extract from Pilosocereus gounellei (Cactaceae) and its chemopreventive effect against cyclophosphamide-induced DNA damage. Heliyon 2020; 6:e03811. [PMID: 32346640 PMCID: PMC7182672 DOI: 10.1016/j.heliyon.2020.e03811] [Citation(s) in RCA: 5] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/22/2019] [Revised: 01/28/2020] [Accepted: 04/16/2020] [Indexed: 12/03/2022] Open
Abstract
Pilosocereus gounellei (Cactaceae) is used to treat wounds and inflammation. In this study, we evaluated whether the saline extract from its stem would have genotoxic or anti-genotoxic effects. In the genotoxicity evaluation, mice received the extract (500, 1,000, or 2,000 mg/kg) orally while negative and positive controls were treated with saline solution (0.9% NaCl) per os and cyclophosphamide (CPA, 80 mg/kg i.p.), respectively. In the anti-genotoxicity assay, using other animals, treatments were carried out by administering the extract (500, 1,000 or 2,000 mg/kg) or saline solution (negative control) per os and then CPA (80 mg/kg i.p.) 1 h later. Genotoxic effects were evaluated by micronucleus test and comet assay using peripheral blood and bone marrow cells. Oral administration of only the extract at 500 and 1,000 mg/kg did not result in genotoxicity. A slight increase in the incidence of micronucleus was observed at the highest dose (2,000 mg/kg). Administration of the extract before CPA reduced the micronucleated polychromatic erythrocytes (MNPCE) number by 49.07–71.43%, and DNA fragmentation in peripheral blood (85.04–94.44%) and bone marrow (87.43–92.70%) cells also decreased. In conclusion, when administered orally at the tested doses, the extract is genotoxically safe, being cautious in doses above 1,000 mg/kg, and has a protective effect against CPA-induced DNA damage.
Collapse
Affiliation(s)
- Alisson Macário de Oliveira
- Departamento de Bioquímica, Centro de Biociências, Universidade Federal de Pernambuco, Recife, Pernambuco, Brazil
| | | | - Patrícia Maria Guedes Paiva
- Departamento de Bioquímica, Centro de Biociências, Universidade Federal de Pernambuco, Recife, Pernambuco, Brazil
| | - Thiago Henrique Napoleão
- Departamento de Bioquímica, Centro de Biociências, Universidade Federal de Pernambuco, Recife, Pernambuco, Brazil
| |
Collapse
|
11
|
Juliano Oliveira R, Pereira FPAN, Silveira IOMFD, Lima RVD, Berno CR, Pesarini JR, Antoniolli-Silva ACMB, Monreal ACD, Adilson B, Lima DPD, Gomes RDS. Assessment of the toxicogenic effects and cell death potential of the ester (Z)-methyl 4-((1,5-dimethyl-3-oxo-2-phenyl-2,3-dihydro-1H-pyrazol-4-yl)amino)-4-oxobut-2-anoate in combination with cisplatin, cyclophosphamide and doxorubicin. Genet Mol Biol 2019; 42:399-410. [PMID: 31259359 PMCID: PMC6726153 DOI: 10.1590/1678-4685-gmb-2017-0279] [Citation(s) in RCA: 5] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/04/2017] [Accepted: 07/17/2018] [Indexed: 12/03/2022] Open
Abstract
Despite rapid advances in both the early detection and treatment of cancer, the
mortality from this disease remains high, which justifies the development of new
products that are more selective and effective and have fewer side effects.
Accordingly, a novel ester was synthesized that contains two pharmacophores with
important biological activities: (I) 4-aminoantipyrine, which has
anti-inflammatory and antioxidant effects, and (II) the pharmacophore
1,4-dioxo-butenyl, which has cytotoxic activity. When administered alone, this
compound is non-genotoxic, and it does not cause an increasing in splenic
phagocytosis. Nevertheless, it can induce cell death. When administered in
combination with commercial chemotherapeutic agents, such as doxorubicin,
cisplatin, and cyclophosphamide, the ester shows antigenotoxic activity and
decreases phagocytosis and reduces the potential to cause cell death. These
results indicate that the compound should not be used in combination with
chemotherapeutic agents that exert their effect through DNA damage, an important
feature of antitumor drugs.
Collapse
Affiliation(s)
- Rodrigo Juliano Oliveira
- Centro de Estudos em Célula Tronco, Terapia Celular e Genética Toxicológica, Hospital Universitário "Maria Aparecida Pedrossian", Empresa Brasileira de Serviços Hospitalares, Campo Grande, MS, Brazil.,Programa de Mestrado em Farmácia, Centro de Ciências Biológicas e da Saúde, Universidade Federal de Mato Grosso do Sul, Campo Grande, MS, Brazil.,Programa de Pós-graduação em Saúde e Desenvolvimento na Região Centro-Oeste, Faculdade de Medicina "Dr. Hélio Mandetta", Universidade Federal de Mato Grosso do Sul, Campo Grande, MS, Brazil.,Programa de Pós-graduação em Genética e Biologia Molecular, Centro de Ciências Biológicas, Universidade Estadual de Londrina, Londrina, PR, Brazil
| | - Fabrícia Paniago Ajala Nery Pereira
- Centro de Estudos em Célula Tronco, Terapia Celular e Genética Toxicológica, Hospital Universitário "Maria Aparecida Pedrossian", Empresa Brasileira de Serviços Hospitalares, Campo Grande, MS, Brazil.,Programa de Mestrado em Farmácia, Centro de Ciências Biológicas e da Saúde, Universidade Federal de Mato Grosso do Sul, Campo Grande, MS, Brazil
| | | | - Ricardo Vieira de Lima
- Programa de Pós-graduação em Química, Instituto de Química, Universidade Federal de Mato Grosso do Sul, Campo Grande, MS, Brazil.,Laboratório de Síntese e Modificação Molecular, Faculdade de Ciências Exatas e Tecnologias, Universidade Federal da Grande Dourados, Dourados, MS, Brazil
| | - Claudia Rodrigues Berno
- Centro de Estudos em Célula Tronco, Terapia Celular e Genética Toxicológica, Hospital Universitário "Maria Aparecida Pedrossian", Empresa Brasileira de Serviços Hospitalares, Campo Grande, MS, Brazil.,Programa de Mestrado em Farmácia, Centro de Ciências Biológicas e da Saúde, Universidade Federal de Mato Grosso do Sul, Campo Grande, MS, Brazil
| | - João Renato Pesarini
- Centro de Estudos em Célula Tronco, Terapia Celular e Genética Toxicológica, Hospital Universitário "Maria Aparecida Pedrossian", Empresa Brasileira de Serviços Hospitalares, Campo Grande, MS, Brazil.,Programa de Pós-graduação em Saúde e Desenvolvimento na Região Centro-Oeste, Faculdade de Medicina "Dr. Hélio Mandetta", Universidade Federal de Mato Grosso do Sul, Campo Grande, MS, Brazil.,Graduação em Biomedicina, Universidade Católica Dom Bosco, Campo Grande, MS, Brazil
| | - Andréia Conceição Milan Brochado Antoniolli-Silva
- Centro de Estudos em Célula Tronco, Terapia Celular e Genética Toxicológica, Hospital Universitário "Maria Aparecida Pedrossian", Empresa Brasileira de Serviços Hospitalares, Campo Grande, MS, Brazil.,Programa de Pós-graduação em Saúde e Desenvolvimento na Região Centro-Oeste, Faculdade de Medicina "Dr. Hélio Mandetta", Universidade Federal de Mato Grosso do Sul, Campo Grande, MS, Brazil
| | - Antônio Carlos Duenhas Monreal
- Mestrado em Ciências Veterinárias, Faculdade de Medicina Veterinária e Zootecnia, Universidade Federal de Mato Grosso do Sul, Campo Grande, MS, Brazil
| | - Beatriz Adilson
- Programa de Mestrado em Farmácia, Centro de Ciências Biológicas e da Saúde, Universidade Federal de Mato Grosso do Sul, Campo Grande, MS, Brazil.,Programa de Pós-graduação em Química, Instituto de Química, Universidade Federal de Mato Grosso do Sul, Campo Grande, MS, Brazil
| | - Dênis Pires de Lima
- Programa de Mestrado em Farmácia, Centro de Ciências Biológicas e da Saúde, Universidade Federal de Mato Grosso do Sul, Campo Grande, MS, Brazil.,Programa de Pós-graduação em Química, Instituto de Química, Universidade Federal de Mato Grosso do Sul, Campo Grande, MS, Brazil
| | - Roberto da Silva Gomes
- Programa de Pós-graduação em Química, Instituto de Química, Universidade Federal de Mato Grosso do Sul, Campo Grande, MS, Brazil.,Laboratório de Síntese e Modificação Molecular, Faculdade de Ciências Exatas e Tecnologias, Universidade Federal da Grande Dourados, Dourados, MS, Brazil.,Chemistry and Chemical Biology Department, Harvard University, Cambridge, MA, USA
| |
Collapse
|
12
|
Navarro SD, Pessatto LR, Meza A, de Oliveira EJT, Auharek SA, Vilela LC, de Lima DP, de Azevedo RB, Kassuya CAL, Cáceres OIA, da Silva Gomes R, Beatriz A, Oliveira RJ, Martines MAU. Resorcinolic lipid 3-heptyl-3,4,6-trimethoxy-3H-isobenzofuran-1-one is a strategy for melanoma treatment. Life Sci 2018; 209:300-312. [PMID: 30102904 DOI: 10.1016/j.lfs.2018.08.022] [Citation(s) in RCA: 12] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/22/2018] [Revised: 08/02/2018] [Accepted: 08/08/2018] [Indexed: 12/12/2022]
Abstract
AIMS Previous studies performed by our research group indicated that cytosporone analogues are capable of prevent or repair DNA damages. This work presents the evaluation of the activity of AMS35AA for metastatic murine melanoma cells (B16F10) in experimental model in vitro and, in pre-clinic assay of metastatic melanoma in vivo, using mice lineage C57BL/6. MAIN METHODS In vitro assays were performed: MTT and comet assay, flow cytometry evaluation, gene expression assay by RT-PCR, qualitative evaluation of cell death using B16F10 cells. In vivo assays: micronucleus and comet assay, splenic phagocytosis, melanoma murine model and histopathological analysis, using mice lineage C57BL/6 (n = 20). KEY FINDINGS In vitro results performed by MTT assay showed that AMS35AA is cytotoxic for B16F10 cells (p < 0.05). Based on comet assay the genotoxicity of the IC50 was determined (95.83 μg/mL) (p < 0.05). These data were corroborated by flow cytometry analysis after the treatment with AMS35AA, which indicates the cellular death by apoptosis (p < 0.05) and increasing of ATR, p53, p21 and GADD45 gene expressions verified using RT-PCR. With respect to in vivo results, it was observed that AMS35AA did not show genotoxic activity. Data of tumor volume ex vivo indicate reduction of tumor for the treated animals with AMS35AA up to 15.84×, which is superior to Dacarbazina (50 mg/Kg, p.c.; i.p.). SIGNIFICANCE In summary, the study showed that AMS35AA reveals relevant results regarding to cytotoxicity of B16F10 murine melanoma cells, inducing death by apoptosis via mitochondrial and/or mediated by DNA damages.
Collapse
Affiliation(s)
- Stephanie Dynczuki Navarro
- Graduate Program in Biotechnology and Biodiversity, Pro Midwest Network, Faculty of Pharmaceutical Sciences, Food and Nutrition, Federal University of Mato Grosso do Sul, Campo Grande, Mato Grosso do Sul, Brazil
| | - Lucas Roberto Pessatto
- Research Center in Stem Cells, Cell Therapy and Genetic Toxicology (CeTroGen), "Maria Aparecida Pedrossian" University Hospital, Campo Grande, Mato Grosso do Sul, Brazil; Graduate Program in Genetics and Molecular Biology, General Biology Department, Biological Sciences Center, State University of Londrina, Londrina, Paraná, Brazil
| | - Alisson Meza
- Graduate Program in Chemistry, Chemistry Institute, Federal University of Mato Grosso do Sul, Campo Grande, Mato Grosso do Sul, Brazil
| | - Edwin José Torres de Oliveira
- Research Center in Stem Cells, Cell Therapy and Genetic Toxicology (CeTroGen), "Maria Aparecida Pedrossian" University Hospital, Campo Grande, Mato Grosso do Sul, Brazil; Graduate Program in Genetics and Molecular Biology, General Biology Department, Biological Sciences Center, State University of Londrina, Londrina, Paraná, Brazil
| | - Sarah Alves Auharek
- Faculty of Medicine, Federal University of Jequitinhonha and Mucuri Valleys, Teófilo Otoni, Minas Gerais, Brazil
| | - Lizia Colares Vilela
- Faculty of Medicine, Federal University of Jequitinhonha and Mucuri Valleys, Teófilo Otoni, Minas Gerais, Brazil
| | - Dênis Pires de Lima
- Graduate Program in Chemistry, Chemistry Institute, Federal University of Mato Grosso do Sul, Campo Grande, Mato Grosso do Sul, Brazil
| | - Ricardo Bentes de Azevedo
- Genetics and Morphology Department, Biosciences Institute, Brasilia University, Brasilia, Federal District, Brazil
| | | | - Osmar Ignacio Ayala Cáceres
- Graduate Program in Chemistry, Chemistry Institute, Federal University of Mato Grosso do Sul, Campo Grande, Mato Grosso do Sul, Brazil
| | - Roberto da Silva Gomes
- Graduate Program in Chemistry, Chemistry Institute, Federal University of Mato Grosso do Sul, Campo Grande, Mato Grosso do Sul, Brazil; Synthesis and Molecular Modification Laboratory, Faculty of Exact Sciences and Technology, Federal University of Grande Dourados, Dourados, Mato Grosso do Sul, Brazil
| | - Adilson Beatriz
- Graduate Program in Chemistry, Chemistry Institute, Federal University of Mato Grosso do Sul, Campo Grande, Mato Grosso do Sul, Brazil
| | - Rodrigo Juliano Oliveira
- Research Center in Stem Cells, Cell Therapy and Genetic Toxicology (CeTroGen), "Maria Aparecida Pedrossian" University Hospital, Campo Grande, Mato Grosso do Sul, Brazil; Graduate Program in Genetics and Molecular Biology, General Biology Department, Biological Sciences Center, State University of Londrina, Londrina, Paraná, Brazil; Graduate Program in Health and Development of Midwest Region, Faculty of Medicine "Dr Hélio Mandetta", Federal University of Mato Grosso do Sul, Campo Grande, Mato Grosso do Sul, Brazil.
| | - Marco Antonio Utrera Martines
- Graduate Program in Biotechnology and Biodiversity, Pro Midwest Network, Faculty of Pharmaceutical Sciences, Food and Nutrition, Federal University of Mato Grosso do Sul, Campo Grande, Mato Grosso do Sul, Brazil; Graduate Program in Chemistry, Chemistry Institute, Federal University of Mato Grosso do Sul, Campo Grande, Mato Grosso do Sul, Brazil.
| |
Collapse
|
13
|
Oliveira RJ, da Cruz Leite Santos N, Pesarini JR, de Oliveira BC, Berno CR, de Araújo FHS, da Silveira IOMF, Nascimento RO, Brochado Antoniolli-Silva ACM, Duenhas Monreal AC, Beatriz A, de Lima DP, da Silva Gomes R. Assessment of genetic integrity, splenic phagocytosis and cell death potential of (Z)-4-((1,5-dimethyl-3-oxo-2-phenyl-2,3dihydro-1H-pyrazol-4-yl) amino)-4-oxobut-2-enoic acid and its effect when combined with commercial chemotherapeutics. Genet Mol Biol 2018; 41:154-166. [PMID: 29473933 PMCID: PMC5901497 DOI: 10.1590/1678-4685-gmb-2017-0091] [Citation(s) in RCA: 8] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/04/2017] [Accepted: 08/14/2017] [Indexed: 12/25/2022] Open
Abstract
The increased incidence of cancer and its high treatment costs have encouraged
the search for new compounds to be used in adjuvant therapies for this disease.
This study discloses the synthesis of
(Z)-4-((1,5-dimethyl-3-oxo-2-phenyl-2,3dihydro-1H-pyrazol-4-yl)
amino)-4-oxobut-2-enoic acid (IR-01) and evaluates not only the action of this
compound on genetic integrity, increase in splenic phagocytosis and induction of
cell death but also its effects in combination with the commercial
chemotherapeutic agents doxorubicin, cisplatin and cyclophosphamide. IR-01 was
designed and synthesized based on two multifunctionalyzed structural fragments:
4-aminoantipyrine, an active dipyrone metabolite, described as an antioxidant
and anti-inflammatory agent; and the pharmacophore fragment 1,4-dioxo-2-butenyl,
a cytotoxic agent. The results indicated that IR-01 is an effective
chemoprotector because it can prevent clastogenic and/or aneugenic damage, has
good potential to prevent genomic damage, can increase splenic phagocytosis and
lymphocyte frequency and induces cell death. However, its use as an adjuvant in
combination with chemotherapy is discouraged since IR-01 interferes in the
effectiveness of the tested chemotherapeutic agents. This is a pioneer study as
it demonstrates the chemopreventive effects of IR-01, which may be associated
with the higher antioxidant activity of the precursor structure of
4-aminoantipyrine over the effects of the 1,4-dioxo-2-butenyl fragment.
Collapse
Affiliation(s)
- Rodrigo Juliano Oliveira
- Centro de Estudos em Células Tronco, Terapia Celular e Genética Toxicológica, Hospital Universitário "Maria Aparecida Pedrossian", Empresa Brasileira de Serviços Hospitalares, Campo Grande, MS, Brazil.,Programa de Mestrado em Farmácia, Centro de Ciências Biológicas e da Saúde, Universidade Federal de Mato Grosso do Sul, Campo Grande, MS, Brazil.,Programa de Pós-graduação em Saúde e Desenvolvimento na Região Centro-Oeste, Faculdade de Medicina "Dr. Hélio Mandetta", Universidade Federal de Mato Grosso do Sul, Campo Grande, MS, Brazil
| | - Naiara da Cruz Leite Santos
- Centro de Estudos em Células Tronco, Terapia Celular e Genética Toxicológica, Hospital Universitário "Maria Aparecida Pedrossian", Empresa Brasileira de Serviços Hospitalares, Campo Grande, MS, Brazil.,Programa de Mestrado em Farmácia, Centro de Ciências Biológicas e da Saúde, Universidade Federal de Mato Grosso do Sul, Campo Grande, MS, Brazil
| | - João Renato Pesarini
- Centro de Estudos em Células Tronco, Terapia Celular e Genética Toxicológica, Hospital Universitário "Maria Aparecida Pedrossian", Empresa Brasileira de Serviços Hospitalares, Campo Grande, MS, Brazil.,Programa de Pós-graduação em Saúde e Desenvolvimento na Região Centro-Oeste, Faculdade de Medicina "Dr. Hélio Mandetta", Universidade Federal de Mato Grosso do Sul, Campo Grande, MS, Brazil
| | - Beatriz Carneiro de Oliveira
- Centro de Estudos em Células Tronco, Terapia Celular e Genética Toxicológica, Hospital Universitário "Maria Aparecida Pedrossian", Empresa Brasileira de Serviços Hospitalares, Campo Grande, MS, Brazil
| | - Claudia Rodrigues Berno
- Centro de Estudos em Células Tronco, Terapia Celular e Genética Toxicológica, Hospital Universitário "Maria Aparecida Pedrossian", Empresa Brasileira de Serviços Hospitalares, Campo Grande, MS, Brazil.,Programa de Mestrado em Farmácia, Centro de Ciências Biológicas e da Saúde, Universidade Federal de Mato Grosso do Sul, Campo Grande, MS, Brazil
| | - Flávio Henrique Souza de Araújo
- Centro de Estudos em Células Tronco, Terapia Celular e Genética Toxicológica, Hospital Universitário "Maria Aparecida Pedrossian", Empresa Brasileira de Serviços Hospitalares, Campo Grande, MS, Brazil.,Programa de Mestrado em Farmácia, Centro de Ciências Biológicas e da Saúde, Universidade Federal de Mato Grosso do Sul, Campo Grande, MS, Brazil
| | | | - Raquel Oliveira Nascimento
- Laboratório de Síntese e Modificação Molecular, Faculdade de Ciências Exatas e Tecnologias, Universidade Federal da Grande Dourados, Dourados, MS, Brazil
| | - Andréia Conceição Milan Brochado Antoniolli-Silva
- Centro de Estudos em Células Tronco, Terapia Celular e Genética Toxicológica, Hospital Universitário "Maria Aparecida Pedrossian", Empresa Brasileira de Serviços Hospitalares, Campo Grande, MS, Brazil.,Programa de Pós-graduação em Saúde e Desenvolvimento na Região Centro-Oeste, Faculdade de Medicina "Dr. Hélio Mandetta", Universidade Federal de Mato Grosso do Sul, Campo Grande, MS, Brazil
| | - Antônio Carlos Duenhas Monreal
- Programa de Mestrado em Farmácia, Centro de Ciências Biológicas e da Saúde, Universidade Federal de Mato Grosso do Sul, Campo Grande, MS, Brazil
| | - Adilson Beatriz
- Programa de Mestrado em Farmácia, Centro de Ciências Biológicas e da Saúde, Universidade Federal de Mato Grosso do Sul, Campo Grande, MS, Brazil.,Programa de Pós-graduação em Química, Instituto de Química, Universidade Federal de Mato Grosso do Sul, Campo Grande, MS, Brazil
| | - Dênis Pires de Lima
- Programa de Mestrado em Farmácia, Centro de Ciências Biológicas e da Saúde, Universidade Federal de Mato Grosso do Sul, Campo Grande, MS, Brazil.,Programa de Pós-graduação em Química, Instituto de Química, Universidade Federal de Mato Grosso do Sul, Campo Grande, MS, Brazil
| | - Roberto da Silva Gomes
- Programa de Pós-graduação em Química, Instituto de Química, Universidade Federal de Mato Grosso do Sul, Campo Grande, MS, Brazil.,Laboratório de Síntese e Modificação Molecular, Faculdade de Ciências Exatas e Tecnologias, Universidade Federal da Grande Dourados, Dourados, MS, Brazil
| |
Collapse
|
14
|
Roleira FM, Varela CL, Costa SC, Tavares-da-Silva EJ. Phenolic Derivatives From Medicinal Herbs and Plant Extracts: Anticancer Effects and Synthetic Approaches to Modulate Biological Activity. STUDIES IN NATURAL PRODUCTS CHEMISTRY 2018. [DOI: 10.1016/b978-0-444-64057-4.00004-1] [Citation(s) in RCA: 19] [Impact Index Per Article: 3.2] [Reference Citation Analysis] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 12/03/2022]
|
15
|
Santos Radai JA, da Silva Graciani F, Berno CR, Leitão MM, Dos Santos EP, Oliveira RJ, Kassuya CAL. Genetic toxicological assessment and anti-arthritic effects of an ethanolic extract obtained from Salvia lachnostachys Benth leaves in mice. Regul Toxicol Pharmacol 2017; 92:239-244. [PMID: 29233772 DOI: 10.1016/j.yrtph.2017.12.006] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/12/2017] [Revised: 11/20/2017] [Accepted: 12/08/2017] [Indexed: 12/18/2022]
Abstract
In the present study, mice were subjected to prolonged treatment with ethanolic extract of Salvia lachnostachys Benth leaves (SLEE), and the inflammatory and arthritic parameters were evaluated using the Complete Freund's Adjuvant (CFA) model. The genotoxicity of SLEE were also assayed using genetic toxicological tests. For the CFA model, 28 male C57BL/6 mice were distributed randomly into four groups (control, 50 mg/kg of SLEE, 100 mg/kg of SLEE and dexamethasone) for the evaluation of hyperalgesia and paw edema for 21 days after injection of CFA into the paw. To conduct the toxicogenetic assessments (comet assay and micronuclei assay), apoptosis and splenic phagocytosis were evaluated in male Swiss mice after the administration of saline (control group), cyclophosphamide (positive control group) and SLEE (10, 100 and 1000 mg/kg). SLEE significantly reduced the mechanical hyperalgesia and edema caused by CFA injection. The results of the toxicogenetic assessment revealed no toxicogenetic potential in the mice, and the evaluation of apoptosis showed an increase in apoptotic cells in the spleen after 72 h of treatment with SLEE (1000 mg/kg). SLEE exhibited anti-arthritic activity with no toxicogenetic damage. These toxicogenic results support the safety of SLEE.
Collapse
Affiliation(s)
- Joyce Alencar Santos Radai
- Federal University of Grande Dourados, College Exact Sciences and Technology, Dourados, Mato Grosso do Sul, Brazil.
| | | | - Claudia Rodrigues Berno
- Federal University of Mato Grosso Do Sul, College of Health Science, Campo Grande, MS, Brazil
| | - Maicon Matos Leitão
- Federal University of Grande Dourados, College of Health Science, Dourados, MS, Brazil
| | | | | | | |
Collapse
|
16
|
Schneider BUC, Meza A, Beatriz A, Pesarini JR, Carvalho PCD, Mauro MDO, Karaziack CB, Cunha-Laura AL, Monreal ACD, Matuo R, Lima DPD, Oliveira RJ. Cardanol: toxicogenetic assessment and its effects when combined with cyclophosphamide. Genet Mol Biol 2016; 39:279-89. [PMID: 27303909 PMCID: PMC4910563 DOI: 10.1590/1678-4685-gmb-2015-0170] [Citation(s) in RCA: 12] [Impact Index Per Article: 1.5] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/13/2015] [Accepted: 12/20/2015] [Indexed: 01/17/2023] Open
Abstract
Cardanol is an effective antioxidant and is a compound with antimutagenic and
antitumoral activity. Here, we evaluated the genotoxic and mutagenic potential of
saturated side chain cardanol and its effects in combination with cyclophosphamide in
preventing DNA damage, apoptosis, and immunomodulation. Swiss mice were treated with
cardanol (2.5, 5 and 10 mg/kg) alone or in combination with cyclophosphamide (100
mg/kg). The results showed that cardanol is an effective chemopreventive compound,
with damage reduction percentages that ranged from 18.9 to 31.76% in the comet assay
and from 45 to 97% in the micronucleus assay. Moreover, cardanol has the ability to
reduce the frequency of apoptosis induced by cyclophosphamide. The compound did not
show immunomodulatory activity. A final interpretation of the data showed that,
despite its chemoprotective capacity, cardanol has a tendency to induce DNA damage.
Hence, caution is needed if this compound is used as a chemopreventive agent. Also,
this compound is likely not suitable as an adjuvant in chemotherapy treatments that
use cyclophosphamide.
Collapse
Affiliation(s)
- Beatriz Ursinos Catelan Schneider
- Programa de Pós-Graduação em Saúde e Desenvolvimento na Região Centro-Oeste, Faculdade de Medicina "Dr. Hélio Mandetta", Universidade Federal de Mato Grosso do Sul, Campo Grande, MS, Brazil.,Centro de Estudos em Células-Tronco, Terapia Celular e Genética Toxicológica, Hospital Universitário "Maria Aparecida Pedrossian", Empresa Brasileira de Serviços Hospitalares, Campo Grande, MS, Brazil
| | - Alisson Meza
- Programa de Pós-Graduação em Química, Instituto de Química, Universidade Federal de Mato Grosso do Sul, Campo Grande, MS, Brazil
| | - Adilson Beatriz
- Programa de Pós-Graduação em Química, Instituto de Química, Universidade Federal de Mato Grosso do Sul, Campo Grande, MS, Brazil.,Programa de Mestrado em Farmácia, Centro de Ciências Biológicas e da Saúde, Universidade Federal de Mato Grosso do Sul, Campo Grande, MS, Brazil
| | - João Renato Pesarini
- Programa de Pós-Graduação em Saúde e Desenvolvimento na Região Centro-Oeste, Faculdade de Medicina "Dr. Hélio Mandetta", Universidade Federal de Mato Grosso do Sul, Campo Grande, MS, Brazil.,Centro de Estudos em Células-Tronco, Terapia Celular e Genética Toxicológica, Hospital Universitário "Maria Aparecida Pedrossian", Empresa Brasileira de Serviços Hospitalares, Campo Grande, MS, Brazil
| | - Pamela Castilho de Carvalho
- Programa de Pós-Graduação em Saúde e Desenvolvimento na Região Centro-Oeste, Faculdade de Medicina "Dr. Hélio Mandetta", Universidade Federal de Mato Grosso do Sul, Campo Grande, MS, Brazil.,Centro de Estudos em Células-Tronco, Terapia Celular e Genética Toxicológica, Hospital Universitário "Maria Aparecida Pedrossian", Empresa Brasileira de Serviços Hospitalares, Campo Grande, MS, Brazil
| | - Mariana de Oliveira Mauro
- Programa de Doutorado em Biotecnologia e Biodiversidade - Rede Pró Centro-Oeste, Universidade Federal de Mato Grosso do Sul, Campo Grande, MS, Brazil
| | - Caroline Bilhar Karaziack
- Programa de Pós-Graduação em Química, Instituto de Química, Universidade Federal de Mato Grosso do Sul, Campo Grande, MS, Brazil
| | - Andréa Luiza Cunha-Laura
- Programa de Mestrado em Farmácia, Centro de Ciências Biológicas e da Saúde, Universidade Federal de Mato Grosso do Sul, Campo Grande, MS, Brazil
| | - Antônio Carlos Duenhas Monreal
- Programa de Mestrado em Farmácia, Centro de Ciências Biológicas e da Saúde, Universidade Federal de Mato Grosso do Sul, Campo Grande, MS, Brazil
| | - Renata Matuo
- Centro de Estudos em Células-Tronco, Terapia Celular e Genética Toxicológica, Hospital Universitário "Maria Aparecida Pedrossian", Empresa Brasileira de Serviços Hospitalares, Campo Grande, MS, Brazil.,Programa de Mestrado em Farmácia, Centro de Ciências Biológicas e da Saúde, Universidade Federal de Mato Grosso do Sul, Campo Grande, MS, Brazil
| | - Dênis Pires de Lima
- Programa de Pós-Graduação em Química, Instituto de Química, Universidade Federal de Mato Grosso do Sul, Campo Grande, MS, Brazil
| | - Rodrigo Juliano Oliveira
- Programa de Pós-Graduação em Saúde e Desenvolvimento na Região Centro-Oeste, Faculdade de Medicina "Dr. Hélio Mandetta", Universidade Federal de Mato Grosso do Sul, Campo Grande, MS, Brazil.,Centro de Estudos em Células-Tronco, Terapia Celular e Genética Toxicológica, Hospital Universitário "Maria Aparecida Pedrossian", Empresa Brasileira de Serviços Hospitalares, Campo Grande, MS, Brazil.,Programa de Mestrado em Farmácia, Centro de Ciências Biológicas e da Saúde, Universidade Federal de Mato Grosso do Sul, Campo Grande, MS, Brazil
| |
Collapse
|